ABIOCOR SURGEONS GIVE UPDATE ON
STATUS OF PATIENTS, PROGRAM
Talk part of opening day of Research!Louisville
(Louisville, Ky.) - The University
of Louisville surgeons who implanted the world's first and second
AbioCor totally implantable replacement hearts on July 2 and September
13 reported on the program's status to a group assembled for Research!Louisville,
Bob Tools, 59, Franklin, Kentucky
"Bob is really enjoying his time outside the
hospital," Gray said during the presentation.
Dowling agreed, and added, "He is doing better
than we ever anticipated - so it's sometimes easy to forget that
he's still sick." Dowling continued, "He needs to gain
about 30 pounds and improve in several nutrition factors before
we can seriously discuss a discharge date."
At this point, the doctors reported, the team
is working on a discharge plan for Mr. Tools, even though no discharge
date has been set. "He's doing exceptionally well," Gray
continued, "but his nutrition is still a major concern."
Tom Christerson, 70, Central City, Kentucky
"Mr. Christerson was returned the ventilator
last week," Gray reported. "He has significant pre-existing
lung disease, and that has been a problem."
"Much of the problem with his breathing has to
do with his general state of muscle weakness," Dowling added.
"It takes quite a bit of strength and energy to breathe deeply
enough for a person his size."
The Research!Louisville luncheon event was presented
by the Jewish Hospital Foundation.
Jewish Hospital is among the top 10 cardiac centers
in the United States and, along with the University of Louisville,
is dedicated to excellence in patient care, research and education.
University of Louisville surgeons at Jewish Hospital have performed
many heart care "firsts," including Kentucky's first heart
transplant, the world's first heart transplant following the use
of a Thoratec bi-ventricular assist device, the world's first endoscopic
saphenous vein harvest and the first ventricular remodeling in the
friendly version (Adobe
Acrobat Reader Required)